By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CRISPR Therapeutics 

675 West Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-580-9212 Fax: n/a


SEARCH JOBS

CRISPR Therapeutics is a leading gene editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing platform. CRISPR is a revolutionary technology that allows for precise, directed changes to genomic DNA. The Company’s multi-disciplinary team of world-class researchers and drug developers is working on a number of wholly-owned programs to treat serious diseases with high unmet need.

YEAR FOUNDED:

November 2013

LEADERSHIP:

Founders: Rodger Novak, Emmanuelle Charpentier, Shaun Foy

Scientific Founders: Chad Cowan, Daniel Anderson, Stephen Elledge, Craig Mello, Matthew Porteus

CEO and Co-founder: Rodger Novak

CFO: Marc Becker

CSO (Scientific): Sven Ante (Bill) Lundberg

JOBS:

Please click here for CRISPR Therapeutics job opportunities.

FOLLOW CRISPR THERAPEUTICS:






Key Statistics


Email: info@crisprtx.com
Ownership: Public

Web Site: CRISPR
Employees:
Symbol: CRSP
 









Company News
CRISPR (CRSP) Announces Collaboration With Massachusetts General Hospital To Research Use Of CRISPR/Cas9 In T Cell Cancer Therapies 8/22/2017 9:51:41 AM
CRISPR (CRSP) Announces Second Quarter 2017 Financial Results And Provides Business Update 8/11/2017 10:51:17 AM
CRISPR (CRSP) Appoints Dr. Tony W. Ho To Head Research & Development 8/1/2017 12:23:56 PM
CRISPR (CRSP) To Lose Its CFO In September, Hunt For Successor Begins 7/27/2017 6:42:16 AM
CRISPR (CRSP), Intellia, Caribou Biosciences And ERS Genomics Announce Appellate Brief Seeking Reversal Of U.S. Patent Board Decision On CRISPR/Cas9 Gene Editing 7/26/2017 10:39:09 AM
CRISPR (CRSP) And Neon Therapeutics Enter Research Collaboration 7/10/2017 8:24:51 AM
CRISPR (CRSP) Announces Patent For CRISPR/Cas Genome Editing In China 6/19/2017 10:22:48 AM
CRISPR (CRSP) And MaSTherCell Sign Service Agreement For The Development And Manufacturing Of Allogeneic Cell Therapies 6/13/2017 12:35:49 PM
CRISPR (CRSP) Appoints James R. Kasinger As General Counsel 6/7/2017 8:21:53 AM
CRISPR (CRSP) And MaSTherCell Sign Service Agreement For The Development And Manufacturing Of Allogeneic Cell Therapies 6/6/2017 7:29:56 AM
12345
//-->